BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3585902)

  • 1. Thromboxane synthetase inhibitors and antihypertensive agents. 3. N-[(1H-imidazol-1-yl)alkyl]heteroaryl amides as potent enzyme inhibitors.
    Press JB; Wright WB; Chan PS; Haug MF; Marsico JW; Tomcufcik AS
    J Med Chem; 1987 Jun; 30(6):1036-40. PubMed ID: 3585902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane synthetase inhibitors and antihypertensive agents. 1. N-[(1H-imidazol-1-yl)alkyl]aryl amides and N-[(1H-1,2,4-triazol-1-yl)alkyl]aryl amides.
    Wright WB; Press JB; Chan PS; Marsico JW; Haug MF; Lucas J; Tauber J; Tomcufcik AS
    J Med Chem; 1986 Apr; 29(4):523-30. PubMed ID: 3959030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane synthetase inhibitors and antihypertensive agents. 4. N-[(1H-imidazol-1-yl)alkyl] derivatives of quinazoline-2,4(1H,3H)-diones, quinazolin-4(3H)-ones, and 1,2,3-benzotriazin-4(3H)-ones.
    Wright WB; Tomcufcik AS; Chan PS; Marsico JW; Press JB
    J Med Chem; 1987 Dec; 30(12):2277-83. PubMed ID: 3681898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino[4,5-b]indole, 4-hydrazinopyridazino[4,5-a]indole, and related compounds.
    Monge A; Parrado P; Font M; Fernández-Alvarez E
    J Med Chem; 1987 Jun; 30(6):1029-35. PubMed ID: 3585901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective thromboxane synthetase inhibitors. 3. 1H-imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene-, and indole-2- and -3-carboxylic acids.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Sep; 29(9):1637-43. PubMed ID: 3746813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane synthetase inhibitors and antihypertensive agents. 2. N-[(1H-imidazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones and N-[(1H-1,2,4-triazol-1-yl)alkyl]-1H-isoindole-1,3(2H)-diones as unique antihypertensive agents.
    Press JB; Wright WB; Chan PS; Marsico JW; Haug MF; Tauber J; Tomcufcik AS
    J Med Chem; 1986 May; 29(5):816-9. PubMed ID: 3517332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective thromboxane synthetase inhibitors. 4. 2-(1H-imidazol-1-ylmethyl) carboxylic acids of benzo[b]furan, benzo[b]thiophene, indole, and naphthalene.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Sep; 29(9):1643-50. PubMed ID: 3091830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Mar; 29(3):342-6. PubMed ID: 3081722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1985 Oct; 28(10):1427-32. PubMed ID: 3930740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis and platelet aggregation inhibitory activity of analogues of 4-([2-(1H-imidazol-1-yl)-1-(4-substituted-phenyl)ethoxy]methyl)benzoic acids].
    Wu QY; Yang JQ
    Yao Xue Xue Bao; 1991; 26(10):741-6. PubMed ID: 1823715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridines.
    Archibald JL; Bradley G; Opalko A; Ward TJ; White JC; Ennis C; Shepperson NB
    J Med Chem; 1990 Feb; 33(2):646-52. PubMed ID: 2299629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(1H-imidazol-1-yl)methyl]- and [(3-pyridinyl)methyl]pyrroles as thromboxane synthetase inhibitors.
    Martinez GR; Walker KA; Hirschfeld DR; Maloney PJ; Yang DS; Rosenkranz RP
    J Med Chem; 1989 Apr; 32(4):890-7. PubMed ID: 2704033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazol-1-yl and pyridin-3-yl derivatives of 4-phenyl-1,4-dihydropyridines combining Ca2+ antagonism and thromboxane A2 synthase inhibition.
    Cozzi P; Carganico G; Fusar D; Grossoni M; Menichincheri M; Pinciroli V; Tonani R; Vaghi F; Salvati P
    J Med Chem; 1993 Oct; 36(20):2964-72. PubMed ID: 8411014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2 synthetase inhibitors with histamine H1-blocking activity: synthesis and evaluation of a new series of indole derivatives.
    Kamiya S; Matsui H; Shirahase H; Nakamura S; Wada K; Kanda M; Shimaji H; Kakeya N
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1692-5. PubMed ID: 8536342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives.
    Navarrete-Vázquez G; Hidalgo-Figueroa S; Torres-Piedra M; Vergara-Galicia J; Rivera-Leyva JC; Estrada-Soto S; León-Rivera I; Aguilar-Guardarrama B; Rios-Gómez Y; Villalobos-Molina R; Ibarra-Barajas M
    Bioorg Med Chem; 2010 Jun; 18(11):3985-91. PubMed ID: 20451399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids.
    Johnson RA; Nidy EG; Aiken JW; Crittenden NJ; Gorman RR
    J Med Chem; 1986 Aug; 29(8):1461-8. PubMed ID: 3735314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF; Browne LJ; Campbell T; Gemenden C; Goldstein R; Gude C; Wasley JW
    J Med Chem; 1985 Feb; 28(2):164-70. PubMed ID: 3918169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
    Dickinson RP; Dack KN; Long CJ; Steele J
    J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of novel nonpeptide angiotensin II receptor antagonists: imidazo[4,5-c]pyridine derivatives with an aromatic substituent.
    Kiyama R; Fuji M; Hara M; Fujimoto M; Kawabata T; Nakamura M; Fujishita T
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):450-60. PubMed ID: 7774028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on heterocyclic compounds. XXXVIII. Synthesis and pharmacological activity of imidazo[1,2-b]pyridazine-2-carboxylic derivatives.
    Luraschi E; Arena F; Sacchi A; Laneri S; Abignente E; Avallone L; D'Amico M; Berrino L; Rossi F
    Farmaco; 1997 Apr; 52(4):213-7. PubMed ID: 9241825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.